BTG3 and preeclampsia: Moreover, the present study conducted a stratified investigation of different ANA titers and revealed that univariate and multivariate interaction analyses between the two groups demonstrated no significant difference in the efficacy of HCQ in improving the incidence of preeclampsia in patients with different ANA titers (Table 4).